首页> 美国卫生研究院文献>Cardiovascular Diabetology >Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
【2h】

Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial

机译:无聚合物西罗莫司和普罗布考洗脱支架与第二代佐他莫司洗脱支架治疗的糖尿病患者的五年临床结果:一项随机对照试验的亚组分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundImproved outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention remain an unmet clinical need. We assessed the long-term efficacy and safety of novel polymer-free sirolimus- and probucol-eluting stent in diabetic patients enrolled in intracoronary stenting and angiographic results: test efficacy of sirolimus- and probucol-eluting versus zotarolimus-eluting stents 5 trial.
机译:背景接受经皮冠状动脉介入治疗的糖尿病患者转归的改善仍未满足临床需求。我们评估了新型无聚合物西罗莫司洗脱和普罗布考尔洗脱支架在冠状动脉内支架置入和血管造影结果中的糖尿病患者的长期疗效和安全性:西罗莫司洗脱和普罗布考洗脱与佐他莫司洗脱支架比较5的试验功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号